Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Dilution
View:
Post by goldtech on Jul 27, 2021 11:20am

Dilution

Years of diluting the hell out of the stock has flooded the market with cheap shares. Goldstein and Williams are the worst team to be involved in any public company. Pro traders are playing with the volume.
Comment by M101 on Jul 27, 2021 1:38pm
Spin from Biogen is not now nor will it ever again drive our stock value for more than a couple of days i.e., the time it takes retail traders to figure out when there is no PMN company news coming. (Of course there's a grey area whenever our management repackages spin from big pharma and their bankers as Promis news, but that hasn't happened (yet) this time.)   Yes, churners ...more  
Comment by DavidKingCanada on Jul 27, 2021 7:10pm
You seem to be PMN's one and only Cheerleader! 
Comment by KingAbeNYC on Jul 27, 2021 2:55pm
Huh uh? I think we already know that lol
ProMIS Neurosciences Inc